LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

2024-515340-23-00 Protocol ICM-URC2016/27 Therapeutic exploratory (Phase II) Authorised, recruitment pending

Status Authorised, recruitment pending · 1 EU/EEA countries · 22 sites · Protocol ICM-URC2016/27

Overview

Sponsor-declared trial summary

Phase Therapeutic exploratory (Phase II)
Status Authorised, recruitment pending
Participants planned 160
Countries 1
Sites 22

Colon cancer

Key facts

Sponsor
Institut Regional Du Cancer De Montpellier
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Decision date (initial)
2024-08-22
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-515340-23-00
EudraCT number
2016-002576-27
ClinicalTrials.gov
NCT03255434

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Colon cancer

VersionLevelCodeTermSystem organ class
21.0 LLT 10009991 Colonic cancer stage III 10029104

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Institut Regional Du Cancer De Montpellier

Sponsor organisation
Institut Regional Du Cancer De Montpellier
Address
208 Avenue Des Apothicaires
City
Montpellier Cedex 5
Postcode
34298
Country
France

Scientific contact point

Organisation
Institut Regional Du Cancer De Montpellier
Contact name
Pr Eric Assenat

Public contact point

Organisation
Institut Regional Du Cancer De Montpellier
Contact name
Chloé Janiszewski

Locations

1 EU/EEA country · 22 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Authorised, recruitment pending 160 22
Rest of world 0

Investigational sites

France

22 sites · Authorised, recruitment pending
Institut Regional Du Cancer De Montpellier
oncology department, 208 Avenue Des Apothicaires, 34298, Montpellier Cedex 5
Centre Hospitalier Regional De Marseille
oncology department, 264 Rue Saint Pierre, 13005, Marseille
Centre Hospitalier De La Cote Basque
oncology department, 13 Avenue Interne Jacques Loeb, 64100, Bayonne
Polyclinique Bordeaux Nord Aquitaine
oncology department, 15 Rue Claude Boucher, Cs 31396, Bordeaux Cedex
Clinique Pasteur Lanroze
oncology department, 32 Rue Auguste Kervern, 29200, Brest
Centre Francois Baclesse
oncol, 3 Avenue Du General Harris, Cs 45026, Caen Cedex 5
Centre Hospitalier Universitaire De Dijon
oncology department, 14 Rue Paul Gaffarel, 21000, Dijon
Centre Hospitalier Departemental Vendee
oncology department, Boulevard Stephane Moreau, 85925, La Roche Sur Yon Cedex 9
Hopital Saint Joseph
oncology department, 26 Boulevard De Louvain, 13008, Marseille
Hopital Europeen Marseille
oncology department, 6 Rue Desiree Clary, 13003, Marseille
Hopital Saint Louis
oncology department, 1 Avenue Claude Vellefaux, 75010, Paris
Centre Hospitalier De Perpignan
oncology department, 20 Avenue Du Languedoc, Cs 49954, Perpignan Cedex
Centre Hospitalier Annecy Genevois
oncology department, 1 Avenue De L Hopital, Bp 90074 Epagny Metz Tessy, Pringy Cedex
Institut Godinot
oncology department, 1 Rue Du General Koenig, 51100, Reims
Centre De Lutte Contre Le Cancer Eugene Marquis
oncology department, Avenue La Bataille Flandre Dunkerque, Cs 44229, Rennes Cedex
Groupe Hospitalier Rance Emeraude
oncology department, 1 Rue De La Marne, 35403, Saint-Malo Cedex
Institut De Cancerologie Strasbourg Europe
oncology department, 17 Rue Albert Calmette, 67200, Strasbourg
Centre Hospitalier Regional Universitaire De Tours
oncology department, Avenue De La Republique, 37170, Chambray Les Tours
CHRU De Nancy
oncology department, Rue Du Morvan, 54500, Vandoeuvre Les Nancy
Institut De Cancerologie De Lorraine
oncology department, 6 Avenue De Bourgogne, 54500, Vandouvre Les Nancy
Centre Hospitalier Universitaire De Montpellier
oncology department, 80 Avenue Augustin Fliche, 34295, Montpellier Cedex 5
CHU De Martinique
oncology department, P. O. Box 90632, 97261, Fort De France Cedex

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-08-01 France Acceptable
2024-08-08
2024-08-22